Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Patrys Limited ( (AU:PAB) ) has provided an update.
Patrys Limited has updated its capital structure following the issuance of new securities. The company now has 340,728,636 fully paid ordinary shares and several unlisted options with varying expiration dates and exercise prices. This update is part of Patrys’ ongoing efforts to strengthen its financial position and support its strategic initiatives in the therapeutic antibody sector.
More about Patrys Limited
Based in Melbourne, Australia, Patrys Limited is a therapeutic antibody development company focused on its deoxymab platform of cell-penetrating antibodies for various therapeutic indications.
Average Trading Volume: 1,346,267
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.86M
For an in-depth examination of PAB stock, go to TipRanks’ Overview page.